National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

moxifloxacin hydrochloride
The hydrochloride salt of a fluoroquinolone antibacterial antibiotic. Moxifloxacin binds to and inhibits the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, resulting in inhibition of DNA replication and repair and cell death in sensitive bacterial species. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand names:Avelox
Viagmox
Abbreviation:MOXI
Code name:BAY 128039



Previous:mouse gp100 plasmid DNA vaccine, mouse prostate-specific membrane antigen plasmid DNA vaccine, MOv-gamma chimeric receptor gene, Movalis, Movatec
Next:Mozobil, MPC-6827, MS Contin, MSir, mTOR kinase inhibitor AZD8055

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov